CA-TRACKFORCE-VALIANT
29.6.2022 16:02:08 CEST | Business Wire | Press release
Trackforce Valiant , a leading provider of security workforce management solutions, today announced the acquisition of TrackTik Software , one of the most innovative and fastest growing cloud-based security workforce management providers. The combination of these two companies has created a new dominant market leader in providing visibility and control for the physical security workforce.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220629005064/en/
“We are very excited to welcome TrackTik into the Trackforce Valiant family,” said Trevor Campion, CEO of Trackforce Valiant. “Now more than ever, we believe in the importance of providing the right security solutions for companies of all sizes and business needs. The addition of TrackTik enables us to provide a wide range of technology options that are purpose-built for the unique needs of physical security operations.”
TrackTik was founded in 2013 with the mission of providing a complete set of tools through easy-to-use software and taking the fear out of technology in order to put it to work for security workforce management. From their origins in Montreal, Canada, TrackTik provides solutions to over 35 countries across 6 continents and has been steadily innovating the way companies leverage workforce technology for security operations. The platform provides a full suite of applications, combining the needs of back-office administration to front line security operations.
As a result of this new venture, physical security companies now can leverage the combined best practices of two leading security workforce management providers, providing multiple options for how they can manage security operations. Additionally, the combined technology teams of Trackforce Valiant and TrackTik Software will enable the company to further innovate and enhance their solutions further than any other software provider in the industry.
“The physical security market continues to grow, and with that so does the need for solutions that can grow with them,” said Simon Ferragne, CEO of TrackTik. “This acquisition positions us as the dominant leader for security workforce technology, and we are thrilled to work together to continue our mission to build innovative, leading-edge solutions for our customers.”
Both companies will continue to maintain operations in service of their customers and partners, with Trevor Campion overseeing the combined organization as CEO, and Simon Ferragne, TrackTik’s CEO, entering the role of CTO. Simon Ferragne and TrackTik’s investors, CDPQ Investissements, Georgian, Klass Capital, Inovia Capital, Intercap, and Schauer Ventures have reinvested a portion of their proceeds in the newly combined entity to help foster continued growth in the company. TrackTik will continue to operate and maintain its presence in Quebec as one of Canada’s top small and medium employers. Trackforce Valiant and TrackTik will collaborate on developing and innovating security solutions that include Time and Labor Management, Guard Touring, Incident Management, Dispatch and Mobile Patrol, as well as Billing and Payroll management.
About Trackforce Valiant
Trackforce Valiant is a leader in complete security workforce management solutions. More than 300,000 professionals at over 30,000 customer sites in 45 countries use Trackforce Valiant every day to ensure the delivery of reliable security services, improve operational efficiency and optimally manage their human capital. For nearly 30 years, Trackforce Valiant has provided fully integrated security solutions to its partners and customers. Thanks to its security expertise and state-of-the-art information systems technology, Trackforce Valiant proudly offers the most effective solutions available on the market. Clients include the world's leading security guard service providers, as well as major airports, universities, and corporations across the globe. Additional information is available at https://www.trackforcevaliant.com .
About TrackTik
Founded in 2013, TrackTik is a privately-owned, VC-backed Canadian scale-up of 200+ employees providing a cloud-based workforce management solution in the physical security industry. Headquartered in Montreal, with offices in the UK and a presence in various provinces in Canada and the Netherlands, TrackTik serves 780 customers in more than 35 countries. TrackTik quickly established itself as a market leader with the mission to seamlessly connect humans, workflows, and systems to deliver a better way of working to the physical security workforce. TrackTik’s integrated suite of automated tools fluidly connects frontline operations and back-office management allowing managers to follow the progression of field workers, reduce manual tasks, lower cost, glean actionable insights from data to demonstrate value, promote operational efficiency and boost productivity, job satisfaction, and retention. Additional information is available at https://www.tracktik.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220629005064/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
